163 filings
Page 3 of 9
6-K
po3te5oaztnn
15 Jul 20
ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostrate Cancer
8:33am
6-K
kjn5i1 79i
22 Jun 20
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Meeting II
9:17am
6-K
0l7zavl5eu5k0a2
27 May 20
ESSA Pharma to Present at Jefferies Virtual Healthcare Conference
8:37am
6-K
9nhm m0zg
15 May 20
ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting
8:34am
6-K
pdxrlu
7 May 20
Current report (foreign)
5:31pm
6-K
ivm4th9uq5ah8hv
1 May 20
ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer
12:00am
6-K
8tfhx
15 Apr 20
Current report (foreign)
5:04pm
6-K
aagqni56n3lm0fw9a6
14 Apr 20
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement
12:00am
6-K
xt8nj7tbr6gjtog
14 Apr 20
Open Market Sale Agreementsm
12:00am
6-K
s3rsa92
31 Mar 20
ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update
9:33am
6-K
rr3me
28 Feb 20
ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders
12:00am
6-K
c9qgbrt
14 Feb 20
Current report (foreign)
12:00am
6-K
5ix0il8516u9iuu0e845
11 Feb 20
ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia
12:00am
6-K
zr3oew6v 86zhz0to
20 Dec 19
Current report (foreign)
12:00am
6-K
84vl3p6c0h
30 Oct 19
Current report (foreign)
9:01am
6-K
ejffk8
28 Oct 19
ESSA Pharma Presents Data on EPI-7386 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
1:02pm
6-K
bq4h 9ughxr6czj7f
21 Oct 19
Material Change Report
3:39pm
6-K
vbk94l8kg 8mjd1u3n71
18 Oct 19
ESSA Announces Changes to its Board of Directors
4:51pm
6-K
aq88b148o7csjm js2l
7 Oct 19
ESSA Pharma Board of Directors Approves Stock Option Plan, RSU Plan and Option Grants
3:18pm
6-K
bf2xwd
30 Sep 19
ESSA Pharma Presents New Data on EPI-7386 at the European Society of Medical Oncology (ESMO) 2019 Congress
9:38am